Drugs / chromium niacinate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01709123 | Aug 2007 → Sep 2013 | type 1 diabetes mellitus | Louisiana State University Health Sciences Center Shreveport | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | chromium niacinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01709123 ↗ |
| Modality | Other / unclassified | “Chromium niacinate is considered a nutrient.” NCT01709123 ↗ |
| Route | Oral | “Chromium niacinate supplementation (200ug or 500ug/day) in pill form for 3 months” NCT01709123 ↗ |